1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2019;2020:2020. https://doi.org/10.1101/2020.02.06.20020974. Accessed 20 Feb 2020.
2. Xu KJ,Cai HL,Shen YH,et a1. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao (Yi Xue Ban). 2020. https://kns.cnki.net/kcms/detail/33.1248.R.20200222.1417.002.html. Accessed 3 Mar 2020 (in Chinese).
3. General Office of the National Health Committee of China, China Traditional Chinese Medicine Administration Office. Diagnosis and treatment plan of novel coronavirus pneumonia (seventh trial edition). 2020. http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml. Accessed 11 Mar 2020.
4. Jennifer RT, Marcus JK, Cameron PS, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.
5. Fei ZY, Dong H, Qian QJ, et al. Analysis of pathogens and risk factors for death in elderly patients with severe pneumonia. Zhong Hua Yi Yuan Gan Ran Xue Za Zhi. 2019;29(3):380–3 (in Chinese).